Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LuminoMark for localization of nonpalpable breast lesions
NCT03743259Phase 2Completed
- Sponsor
- Hanlim Pharm
- Start
- May 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indocyanine green + hyaluronic acid in breast lesion, sponsored by Hanlim Pharm. Started May 2018; status: completed.
02
Drugs
indocyanine green + hyaluronic acid
03
Conditions
breast lesion
Beyond the preview
Go deeper on NCT03743259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03743259.